Acceptance and Commitment Therapy, Selective Serotonin Reuptake Inhibitors and Their Combination in the Improvement of Obsessive-Compulsive Symptoms and Experiential Avoidance in Patients With Obsessive-Compulsive Disorder

BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) and exposure with response prevention for treatment of obsessive-compulsive disorder (OCD) have demonstrated empirical support; however, a substantial number of patients remain with clinically significant OCD symptoms after such treatments....

Descripción completa

Detalles Bibliográficos
Autores principales: Vakili, Yaghoob, Gharaee, Banafsheh, Habibi, Mojtaba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mazandaran University of Medical Sciences 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539588/
https://www.ncbi.nlm.nih.gov/pubmed/26288647
http://dx.doi.org/10.17795/ijpbs845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539588/
https://www.ncbi.nlm.nih.gov/pubmed/26288647
http://dx.doi.org/10.17795/ijpbs845

Ejemplares similares